Related Experiment Videos

Neuropathology of murine mucopolysaccharidosis type VII

B Levy1, N Galvin, C Vogler

  • 1Department of Pathology, St. Louis University School of Medicine, MO 63104, USA.

Acta Neuropathologica
|December 1, 1996
PubMed

Insights

Mucopolysaccharidosis type VII (MPS VII) mice exhibit neuropathology due to beta-glucuronidase deficiency. This genetic model reveals progressive lysosomal storage in the central nervous system, impacting behavior and memory.

Area of Science:

  • Neuroscience
  • Genetics
  • Biochemistry

Background:

  • Mucopolysaccharidosis type VII (MPS VII) is a rare genetic disorder.
  • It results from a deficiency in the lysosomal enzyme beta-glucuronidase.
  • This deficiency leads to the accumulation of glycosaminoglycans.

Purpose of the Study:

  • To characterize the neuropathology in a mouse model of MPS VII.
  • To investigate the impact of beta-glucuronidase deficiency on the central nervous system.
  • To establish the MPS VII mouse as a model for studying lysosomal storage diseases.

Main Methods:

  • Histopathological examination of MPS VII mouse brains.
  • Analysis of lysosomal storage and enzyme activity.
  • Correlation of storage patterns with enzyme levels in normal mice.

Main Results:

  • MPS VII mice display widespread lysosomal distention and glycosaminoglycan accumulation.
  • Progressive lysosomal storage occurs in neurons, glia, and mesenchymal tissues within the CNS.
  • Regional variations in storage within the hippocampus correlate with beta-glucuronidase activity in normal mice.

Conclusions:

  • The MPS VII mouse model accurately reflects the neuropathology of the human disease.
  • This model is valuable for analyzing the effects of therapies on the central nervous system in lysosomal storage disorders.
  • Understanding regional storage patterns is crucial for therapeutic development.

Related Concept Videos